A phase 3, randomised, double-blind study of Trilaciclib or placebo in patients receiving first or second line Gemcitabine and Carboplatin chemotherapy for locally advanced unresectable or metastatic triple-negative breast cancer [G1T28-208] [PRESERVE 2].

  • Antill, Yoland (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Effective start/end date25/11/2131/12/24


  • Medical oncology
  • Breast cancer
  • Clinical trial